↓ Skip to main content

Galantamine for Alzheimer's disease and mild cognitive impairment

Overview of attention for article published in Cochrane database of systematic reviews, January 2006
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
255 Dimensions

Readers on

mendeley
144 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Galantamine for Alzheimer's disease and mild cognitive impairment
Published in
Cochrane database of systematic reviews, January 2006
DOI 10.1002/14651858.cd001747.pub3
Pubmed ID
Authors

Clement Loy, Lon Schneider

Abstract

Galantamine is a specific, competitive, and reversible acetylcholinesterase inhibitor.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
United Kingdom 2 1%
Singapore 1 <1%
Ireland 1 <1%
Brazil 1 <1%
Belgium 1 <1%
Spain 1 <1%
Japan 1 <1%
France 1 <1%
Other 0 0%
Unknown 133 92%

Demographic breakdown

Readers by professional status Count As %
Researcher 26 18%
Student > Bachelor 21 15%
Student > Ph. D. Student 21 15%
Student > Master 20 14%
Student > Postgraduate 12 8%
Other 27 19%
Unknown 17 12%
Readers by discipline Count As %
Medicine and Dentistry 52 36%
Psychology 15 10%
Pharmacology, Toxicology and Pharmaceutical Science 8 6%
Agricultural and Biological Sciences 8 6%
Chemistry 8 6%
Other 33 23%
Unknown 20 14%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2018.
All research outputs
#3,662,640
of 13,459,952 outputs
Outputs from Cochrane database of systematic reviews
#6,555
of 10,601 outputs
Outputs of similar age
#61,024
of 245,649 outputs
Outputs of similar age from Cochrane database of systematic reviews
#129
of 195 outputs
Altmetric has tracked 13,459,952 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 10,601 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 245,649 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 195 others from the same source and published within six weeks on either side of this one. This one is in the 33rd percentile – i.e., 33% of its contemporaries scored the same or lower than it.